3091 Characterization of advanced NSCLC patients with prolonged benefit after veliparib plus carboplatin/paclitaxel: Phase 2 results

التفاصيل البيبلوغرافية
العنوان: 3091 Characterization of advanced NSCLC patients with prolonged benefit after veliparib plus carboplatin/paclitaxel: Phase 2 results
المؤلفون: Caroline Nickner, Normand Blais, Q. Qin, Peter Ansell, Martin Reck, Vera Gorbunova, Suresh S. Ramalingam, Sergey Orlov, Julien Mazieres, Laszlo Urban, Jiang Qian, Mark D. McKee, M. Jones, J. Dziubinski, E. Juhasz, Fabrice Barlesi, Ulrich Keilholz, Vincent L. Giranda, E. Kio
المصدر: European Journal of Cancer. 51:S629-S630
بيانات النشر: Elsevier BV, 2015.
سنة النشر: 2015
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, chemistry.chemical_compound, Veliparib, chemistry, business.industry, Internal medicine, Phase (matter), medicine, business, Carboplatin/paclitaxel
تدمد: 0959-8049
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::e1cc52354d555c52779a95ce2dd26cdb
https://doi.org/10.1016/s0959-8049(16)31732-4
حقوق: CLOSED
رقم الأكسشن: edsair.doi...........e1cc52354d555c52779a95ce2dd26cdb
قاعدة البيانات: OpenAIRE